1 |
DRD1
| [10] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | D00633
D00633
|
Dopamine
| [4] 6 6, 7, 74, 299 |
2 |
DRD1
| [10] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | D02004
D02004
|
Apomorphine
| [3] 5 5, 6, 7 |
3 |
DRD1
| [10] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | D07460
D07460
|
Apomorphine
| [3] 5 5, 6, 7 |
4 |
DRD1
| [10] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | D07870
D07870
|
Dopamine
| [4] 6 6, 7, 74, 299 |
5 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D00633
D00633
|
Dopamine
| [4] 6 6, 7, 74, 299 |
6 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D02004
D02004
|
Apomorphine
| [3] 5 5, 6, 7 |
7 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D07460
D07460
|
Apomorphine
| [3] 5 5, 6, 7 |
8 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D07870
D07870
|
Dopamine
| [4] 6 6, 7, 74, 299 |
9 |
DRD3
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00633
D00633
|
Dopamine
| [4] 6 6, 7, 74, 299 |
10 |
DRD3
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D07870
D07870
|
Dopamine
| [4] 6 6, 7, 74, 299 |
11 |
DRD4
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00633
D00633
|
Dopamine
| [4] 6 6, 7, 74, 299 |
12 |
DRD4
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D07870
D07870
|
Dopamine
| [4] 6 6, 7, 74, 299 |
13 |
DRD5
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00633
D00633
|
Dopamine
| [4] 6 6, 7, 74, 299 |
14 |
DRD5
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse | D07870
D07870
|
Dopamine
| [4] 6 6, 7, 74, 299 |
15 |
MAPT
| [4] MAPK signaling pathway MAPK signaling pathway, Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases | D11210
D11210
|
Flortaucipir
| [3] 5 5, 7, 127 |
16 |
ROCK1
| [20] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Axon guidance, Focal adhesion, Tight junction, Platelet activation, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Yersinia infection, Human cytomegalovirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer | D07941
D07941
|
Fasudil
| [4] 2 2, 5, 7, 51 |
17 |
SNAP25
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | D00783
D00783
|
Botulinum toxin type A
| [13] 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
18 |
ROCK2
| [21] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Axon guidance, Focal adhesion, Tight junction, Platelet activation, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Yersinia infection, Human cytomegalovirus infection, Pathways in cancer, Proteoglycans in cancer, Lipid and atherosclerosis | D07941
D07941
|
Fasudil
| [4] 2 2, 5, 7, 51 |